SNG — Synairgen Income Statement
0.000.00%
Last trade - 00:00- £10.48m
- £1.88m
Annual income statement for Synairgen, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 4.82 | 17.7 | 57.9 | 20.3 | 10.3 |
| Operating Profit | -4.82 | -17.7 | -57.9 | -20.3 | -10.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -4.79 | -17.7 | -57.9 | -20.1 | -9.66 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.88 | -13.9 | -48.7 | -17.6 | -8.41 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.88 | -13.9 | -48.7 | -17.6 | -8.41 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.88 | -13.9 | -48.7 | -17.6 | -8.41 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.025 | -0.068 | -0.175 | -0.063 | -0.03 |